Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient starts over prior year Planning for the transition of CGM commercial responsibility from Ascensia Diabetes Care back to Senseonics GERMANTOWN, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people w ...

Conference call and webcast today at 4:30 p.m. ET LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) ("FAT Brands" or the "Company") today reported financial results for the fiscal third quarter ended September 28, 2025. Andy Wiederhorn, Chairman and CEO of FAT Brands, said, "We delivered strong results across multiple areas in the third quarter, marking our best performance of the year to date. Notably, our casual dining segment posted same-store sales g ...

"As a result of our strong performance so far this year and our continued investment and operational execution, we are again raising our global collections guidance and now expect our full-year 2025 collections to be approximately $2.55 billion, reflecting year-over-year growth of 18%. Our guidance for portfolio purchasing remains unchanged as we still anticipate our global portfolio purchases this year will exceed the $1.35 billion of purchases we made in 2024 as MCM is poised to surpass their record level ...

Accessibility StatementSkip Navigation – Modeyso™ approved as the first and only treatment for recurrent H3 K27M-mutant DMG – – Zepzelcaand atezolizumab (Tecentriq) combination approved as maintenance therapy in 1L ES-SCLC – – 3Q25 total revenues increased 7% year-over-year driven by robust growth of Epidiolex, Xywavand the launch of Modeyso – DUBLIN, Nov. 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter of 2025 and updated financial g ...

FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights "Our third quarter results are encouraging and demonstrate the strength of our established brand and technology and our market leadership position," said Wenbin Jiang, CEO of Cytek Biosciences. "As we look ahead, our team remains sharply focused ...

Revenues up 100% year-over-year to a record $1.27 billion Net Deposits were a record $20 billion, and Robinhood Gold Subscribers reached a record 3.9 million Diluted EPS up 259% year-over-year to $0.61 Robinhood now up to 11 business lines each generating ~$100 million or more in annualized revenues MENLO PARK, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. ("Robinhood") (NASDAQ: HOOD) today announced financial results for the third quarter of 2025, which ended September 30, 2025. "Our te ...

3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase 3Q 2025 GAAP Net Income of $36.4 Million, a 1% YoY Increase 3Q 2025 Adjusted EBITDA of $58.7 Million, a 29% YoY Increase 3Q 2025 Adjusted Net Income of $38.9 Million, an 8% YoY Increase FDA Lot Release of First Yield-Enhanced Production Batches Positions ADMA for Margin Expansion Beginning in 4Q 2025 and Continuing Through 2026 Positive, Statistically Significant Real-World Health Outcomes Demonstrated for ASCENIV™ Record ASCENIV Demand and Anticip ...

ANDOVER, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. ("Byrna" or the "Company") (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today announced that it is experiencing traction with houses of worship and schools as growing national attention shifts towards less-lethal protection options. Byrna's mission to provide an effective means of defense without resorting to deadly f ...

JOHANNESBURG, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the first quarter of fiscal 2026 ("Q1 2026"). Q1 2026 performance: All growth rates are year-on-year between Q1 FY2026 and Q1 FY2025. (1) Average exchange rates applicable for the purpose of translating our results of operations: ZAR 17.67 to $1 for Q1 2026, ZAR 17.72 to $1 for Q1 2025. (2) Non-GAAP measure. Refer to Attachment A of press release for full reconciliation of non-GAAP m ...

DELAWARE, Ohio, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a world leader in industrial packaging products and services, today announced two-month fourth quarter and eleven-month fiscal 2025 results. On June 30, 2025, we entered into a definitive agreement to divest our containerboard business, including our CorrChoice sheet feeder system (the "Containerboard Business"), in an all-cash transaction for $1.8 billion to Packaging Corporation of America. The transaction closed as of Augus ...